text
"['\n4. 매출실적(상세)\n☞ 본문 위치로 이동\n(단위 : 백만원)\n사업부문\n매출유형\n품 목\n제67기 반기\n제66기\n제65기\n의약품제조및판매업\n제 \xa0품\n* 테넬리아 群\xa0\n내수\n23,157\n44,235\n46,647\n수출\n-\xa0\n-\xa0\n-\xa0\n계\n23,157\n44,235\n46,647\n** 케토톱 群\xa0\n내수\n22,516\n54,331\n52,877\n수출\n622\n1,393\n1,424\n계\n23,138\n55,724\n54,301\n*** 아마릴 群\n내수\n15,608\n31,631\n34,192\n수출\n4,627\n5,968\n18,079\n계\n20,235\n37,599\n52,271\n**** 훼스탈 群\n내수\n8,874\n16,330\n13,563\n수출\n-\xa0\n-\xa0\n-\xa0\n계\n8,874\n16,330\n13,563\n데피텔리오\n내수\n4,017\n8,568\n7,793\n수출\n-\xa0\n-\xa0\n-\xa0\n계\n4,017\n8,568\n7,793\n***** 트리테이스 群\n내수\n2,296\n4,748\n5,171\n수출\n-\xa0\n-\xa0\n-\xa0\n계\n2,296\n4,748\n5,171\n기타\n내수\n22,598\n46,232\n49,506\n수출\n677\n1,140\n965\n계\n23,275\n47,372\n50,472\n합 계\n내수\n99,066\n206,075\n209,749\n수출\n5,926\n8,501\n20,468\n합계\n104,992\n214,576\n230,217\n상 \xa0품\n미쎄라\n내수\n11,301\n22,847\n20,826\n수출\n-\xa0\n-\xa0\n-\xa0\n계\n11,301\n22,847\n20,826\n란투스\n내수\n6,897\n5,705\n-\xa0\n수출\n-\xa0\n-\xa0\n-\xa0\n계\n6,897\n5,705\n-\xa0\n스틸녹스\n내수\n6,227\n11,990\n12,063\n수출\n-\xa0\n-\xa0\n-\xa0\n계\n6,227\n11,990\n12,063\n자트랄\n내수\n5,999\n11,043\n9,770\n수출\n-\xa0\n-\xa0\n-\xa0\n계\n5,999\n11,043\n9,770\n토비애즈\n내수\n5,055\n8,017\n8,765\n수출\n-\xa0\n-\xa0\n-\xa0\n계\n5,055\n8,017\n8,765\n트리렙탈\n내수\n4,398\n8,453\n8,757\n수출\n-\xa0\n-\xa0\n-\xa0\n계\n4,398\n8,453\n8,757\n기타\n내수\n44,995\n110,714\n122,562\n수출\n\u3000-\xa0\n-\xa0\n129\n계\n44,995\n110,714\n122,691\n합 계\n내수\n84,872\n178,769\n182,743\n수출\n-\xa0\n-\xa0\n129\n합계\n84,872\n178,769\n182,872\n시약 및 의료기기\n상품\n내수\n35,843\n80,933\n83,243\n수출\n-\xa0\n-\xa0\n-\xa0\n합계\n35,843\n80,933\n83,243\n컨슈머헬스\n상품\n내수\n1,235\n1,239\n479\n수출\n194\n323\n-\xa0\n제품\n내수\n4,897\n8,317\n5,674\n수출\n119\n201\n242\n합계\n6,445\n10,080\n6,395\n기타\n용역\n용역수익\n내수\n19,227\n29,530\n29,838\n임대\n건물임대\n내수\n2,100\n4,114\n4,009\n총 \xa0계\n253,479\n518,002\n536,574\n※ 상기 실적은 별도기준입니다.* 테넬리아, 테넬리아엠이 포함되어 있습니다.** 케토톱플라스타, 케토톱엘플라스타, 케토톱겔이 포함되어 있습니다.*** 아마릴, 아마릴엠, 아마릴 멕스, 아마릴SR이 포함되어 있습니다.**** 훼스탈골드, 훼스탈플러스, 훼스탈슈퍼자임이 포함되어 있습니다.***** 트리테이스, 트리테이스 프로텍트, 트리테이스 플러스가 포함되어 있습니다.\n']"
